IT201900020290A1 - Sucrosomal Berberine®, its compositions and their use - Google Patents

Sucrosomal Berberine®, its compositions and their use

Info

Publication number
IT201900020290A1
IT201900020290A1 IT102019000020290A IT201900020290A IT201900020290A1 IT 201900020290 A1 IT201900020290 A1 IT 201900020290A1 IT 102019000020290 A IT102019000020290 A IT 102019000020290A IT 201900020290 A IT201900020290 A IT 201900020290A IT 201900020290 A1 IT201900020290 A1 IT 201900020290A1
Authority
IT
Italy
Prior art keywords
sucrosomal
berberine
compositions
sucrosomal berberine
Prior art date
Application number
IT102019000020290A
Other languages
Italian (it)
Inventor
Andrea Lacorte
Elisa Brilli
Germano Tarantino
Original Assignee
Alesco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco Srl filed Critical Alesco Srl
Priority to IT102019000020290A priority Critical patent/IT201900020290A1/en
Priority to PCT/IB2020/060383 priority patent/WO2021090214A2/en
Publication of IT201900020290A1 publication Critical patent/IT201900020290A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
IT102019000020290A 2019-11-04 2019-11-04 Sucrosomal Berberine®, its compositions and their use IT201900020290A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102019000020290A IT201900020290A1 (en) 2019-11-04 2019-11-04 Sucrosomal Berberine®, its compositions and their use
PCT/IB2020/060383 WO2021090214A2 (en) 2019-11-04 2020-11-04 Sucrosomial® berberine, its compositions and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000020290A IT201900020290A1 (en) 2019-11-04 2019-11-04 Sucrosomal Berberine®, its compositions and their use

Publications (1)

Publication Number Publication Date
IT201900020290A1 true IT201900020290A1 (en) 2021-05-04

Family

ID=69811639

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102019000020290A IT201900020290A1 (en) 2019-11-04 2019-11-04 Sucrosomal Berberine®, its compositions and their use

Country Status (1)

Country Link
IT (1) IT201900020290A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007113748A1 (en) * 2006-03-30 2007-10-11 Rottapharm S.P.A. Oral formulation with beneficial cardiovascular effects, comprising berberine
EP2149377A1 (en) * 2008-07-29 2010-02-03 Velleja Research SRL Compositions containing berberine and/or analogues thereof or extracts containing it, for the prevention and treatment of alterations of the lipid and carbohydrate balance
WO2014009806A1 (en) 2012-07-31 2014-01-16 Alesco S.R.L. Solid composition comprising iron for use in iron deficient conditions
CN106038488A (en) * 2016-07-19 2016-10-26 重庆医科大学 Oil-in-water nano-emulsion capable of obviously improving bioavailability of insoluble medicament and preparation method for oil-in-water nano-emulsion
WO2017027971A1 (en) * 2015-08-17 2017-02-23 Delivra Inc. Transdermal formulations for delivery of berberine compounds, and their use in the treatment of berberine-responsive diseases and conditions
CN106511260A (en) * 2016-12-05 2017-03-22 黑龙江童医生儿童生物制药有限公司 Berberine hydrochloride oral pill dried gel as well as preparation method and applications thereof
WO2019038430A1 (en) * 2017-08-25 2019-02-28 Eleonor Sprl Composition comprising at least one protoberberine alkaloid and its production process
WO2019150225A1 (en) * 2018-02-02 2019-08-08 Indena S.P.A. Compositions comprising berberine

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007113748A1 (en) * 2006-03-30 2007-10-11 Rottapharm S.P.A. Oral formulation with beneficial cardiovascular effects, comprising berberine
EP2149377A1 (en) * 2008-07-29 2010-02-03 Velleja Research SRL Compositions containing berberine and/or analogues thereof or extracts containing it, for the prevention and treatment of alterations of the lipid and carbohydrate balance
WO2014009806A1 (en) 2012-07-31 2014-01-16 Alesco S.R.L. Solid composition comprising iron for use in iron deficient conditions
WO2017027971A1 (en) * 2015-08-17 2017-02-23 Delivra Inc. Transdermal formulations for delivery of berberine compounds, and their use in the treatment of berberine-responsive diseases and conditions
CN106038488A (en) * 2016-07-19 2016-10-26 重庆医科大学 Oil-in-water nano-emulsion capable of obviously improving bioavailability of insoluble medicament and preparation method for oil-in-water nano-emulsion
CN106511260A (en) * 2016-12-05 2017-03-22 黑龙江童医生儿童生物制药有限公司 Berberine hydrochloride oral pill dried gel as well as preparation method and applications thereof
WO2019038430A1 (en) * 2017-08-25 2019-02-28 Eleonor Sprl Composition comprising at least one protoberberine alkaloid and its production process
WO2019150225A1 (en) * 2018-02-02 2019-08-08 Indena S.P.A. Compositions comprising berberine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 10016-20-3
DATABASE GNPD [online] MINTEL; 16 February 2018 (2018-02-16), ANONYMOUS: "Cholesterol Control Dietary Supplement", XP055709186, retrieved from www.gnpd.com Database accession no. 5460213 *
OFFICIAL JOURNAL OF THE EUROPEAN COMMUNITY

Similar Documents

Publication Publication Date Title
EP3778608A4 (en) Polycyclic carbamoylpyridone derivatives, pharmaceutical compositions and use thereof
IL290276A (en) Tetracyclic compound, preparation method and use thereof
EP3848014A4 (en) Water-soluble fullerene topical composition
EA201691194A1 (en) RHC STIMULATORS
IL285302A (en) Compounds, compositions and methods
IL273300A (en) High dosage valbenazine formulation and compositions, methods, and kits related thereto
BR112012004335A2 (en) compound, pharmaceutical composition, and use of the compound.
EP3924341A4 (en) Compounds, compositions and methods
DK3746054T3 (en) Compositions comprising berberine
IL285651A (en) Anti-trem2 antibodies, compositions comprising same and uses thereof
EP3632959A4 (en) Alkylene oxide derivatives, wetting agent, solubilizing agent, and solubilizing composition
EP3746110A4 (en) Etbr antagonist compounds, compositions, and uses
EP3715342A4 (en) Fluorosulfonyl-containing compound, intermediate thereof, preparation method therefor and use thereof
EP3828169A4 (en) Dication compound, preparation method therefor and use thereof
EP3793563A4 (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
GB201901099D0 (en) Methods, uses and compositions
ZA202107499B (en) Compounds, compositions and methods
IL289416A (en) Tricyclic compound, preparation method therefor and use thereof
ITUB20153829A1 (en) Trifluoroalchenyl heterocyclic compounds with nematocidal activity, their agronomic compositions and their use
BR112014025416A2 (en) ANTIMALARIC AGENTS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THEM AND USE OF THE SAME.
EP3845538A4 (en) Dihydroimidazopyrazinone compound, composition including same, and use thereof
IL287809A (en) Anti-bcma antibody conjugate, compositions comprising the same, and methods of making and using the same
EP3790552A4 (en) Combination compositions comprising bisfluoroalkyl-1,4- benzodiazepinone compounds and methods of use thereof
IT201900020290A1 (en) Sucrosomal Berberine®, its compositions and their use
EP3678636A4 (en) Topical kits and compositions and use thereof